Literature DB >> 16565221

Potential role of leptin expression in hepatocellular carcinoma.

S-N Wang1, Y-T Yeh, S-F Yang, C-Y Chai, K-T Lee.   

Abstract

BACKGROUND: Obesity is associated with hepatocellular carcinoma (HCC). The association may result from the aberrant expression of adipokines. AIM: To explore the potential biological effect and prognostic value of leptin, one of the adipokines, in HCC.
METHODS: Immunohistochemistry was used to evaluate the expression of leptin in 68 patients with HCC. The expression of Ki-67 and microvessel density (MVD) of tumorous lesions in HCC were also analysed. The result of leptin expression was further correlated with Ki-67 expression, intratumour MVD, clinicopathological characteristics, overall survival and the postoperative use of medroxyprogesterone acetate (MPA).
RESULTS: High leptin expression was seen in 60.3% of patients with HCC and was significantly correlated with intratumour MVD (high v low; 59.2 (standard deviation 3.2) v 44.2 (19.5), p = 0.004), but not with Ki-67 expression. No marked correlation was seen between leptin expression and clinicopathological characteristics. However, using a multivariate Cox's proportional hazards model, leptin expression was a predictor for improved overall survival of patients with HCC (odds ratio 0.16; 95% confidence interval 0.03 to 0.87; p = 0.033). In addition, the Kaplan-Meier survival curve showed that high leptin expression was associated with a better survival in patients with HCC, treated postoperatively with MPA (p = 0.008, log rank test).
CONCLUSION: High leptin expression was associated with an increased intratumour MVD and thus may be associated with HCC development. In addition, high leptin expression was a predictor for improved survival of patients with HCC, treated postoperatively with MPA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565221      PMCID: PMC1860468          DOI: 10.1136/jcp.2005.035477

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

1.  Plasma leptin is not associated with prostate cancer risk.

Authors:  Pär Stattin; Rudolf Kaaks; Robert Johansson; Randi Gislefoss; Stefan Söderberg; Henrik Alfthan; Ulf-Håkan Stenman; Egil Jellum; Tommy Olsson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

2.  Decreased serum leptin levels in women with uterine leiomyomas.

Authors:  Te-Fu Chan; Jinu-Huang Su; Yueh-Fang Chung; Hsueh-Ling Chang; Shyng-Shiou F Yuan
Journal:  Acta Obstet Gynecol Scand       Date:  2003-02       Impact factor: 3.636

3.  Leptin influences cellular differentiation and progression in prostate cancer.

Authors:  Kenan Saglam; Emin Aydur; Milker Yilmaz; Serdar Göktaş
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

4.  Obesity and cancer risk among white and black United States veterans.

Authors:  Claudine Samanic; Gloria Gridley; Wong-Ho Chow; Jay Lubin; Robert N Hoover; Joseph F Fraumeni
Journal:  Cancer Causes Control       Date:  2004-02       Impact factor: 2.506

5.  Obesity and diabetes as a risk factor for hepatocellular carcinoma.

Authors:  Jean M Regimbeau; Magali Colombat; Philippe Mognol; François Durand; Eddie Abdalla; Claude Degott; Françoise Degos; Olivier Farges; Jacques Belghiti
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

6.  Leptin in relation to hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Ya-Yu Wang; Shih-Yi Lin
Journal:  Horm Res       Date:  2003

7.  Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.

Authors:  Pär Stattin; Richard Palmqvist; Stefan Söderberg; Carine Biessy; Bjarne Ardnor; Göran Hallmans; Rudolf Kaaks; Tommy Olsson
Journal:  Oncol Rep       Date:  2003 Nov-Dec       Impact factor: 3.906

Review 8.  Hepatocellular carcinoma: an epidemiologic view.

Authors:  Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2002 Nov-Dec       Impact factor: 3.062

9.  Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase.

Authors:  Michiko Onuma; Jeffrey D Bub; Thomas L Rummel; Yoshiki Iwamoto
Journal:  J Biol Chem       Date:  2003-08-05       Impact factor: 5.157

Review 10.  The role of leptin in human physiology and pathophysiology.

Authors:  R Janeckova
Journal:  Physiol Res       Date:  2001       Impact factor: 1.881

View more
  25 in total

Review 1.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

Review 2.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

3.  Clinical significance of serum adipokines levels in lung cancer.

Authors:  Theodora Kerenidi; Martha Lada; Agori Tsaroucha; Panagiotis Georgoulias; Parthena Mystridou; Konstantinos I Gourgoulianis
Journal:  Med Oncol       Date:  2013-02-22       Impact factor: 3.064

Review 4.  SERUM LEPTIN LEVENS AND HEPATOCELLULAR CARCINOMA: REVIEW ARTICLE.

Authors:  Luiza Vitelo Andrighetto; Aline Kirjner Poziomyck
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

5.  Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation.

Authors:  Jing Shen; Chih-Ching Yeh; Qiao Wang; Irina Gurvich; Abby B Siegel; Regina M Santella
Journal:  Anticancer Res       Date:  2016-10       Impact factor: 2.480

6.  The pathophysiology of obesity and its clinical manifestations.

Authors:  Richard N Redinger
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-11

Review 7.  Leptin in hepatocellular carcinoma.

Authors:  Shen-Nien Wang; King-Teh Lee; Chen-Guo Ker
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

Review 8.  Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.

Authors:  Yoko Matsuda; Masahito Hagio; Toshiyuki Ishiwata
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

9.  Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.

Authors:  Nikolaos Stefanou; Vassilis Papanikolaou; Yoichi Furukawa; Yusuke Nakamura; Aspasia Tsezou
Journal:  BMC Cancer       Date:  2010-08-19       Impact factor: 4.430

10.  Leptin enhances cholangiocarcinoma cell growth.

Authors:  Giammarco Fava; Gianfranco Alpini; Chiara Rychlicki; Stefania Saccomanno; Sharon DeMorrow; Luciano Trozzi; Cinzia Candelaresi; Julie Venter; Antonio Di Sario; Marco Marzioni; Italo Bearzi; Shannon Glaser; Domenico Alvaro; Luca Marucci; Heather Francis; Gianluca Svegliati-Baroni; Antonio Benedetti
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.